Rank | Gene Set | Z-score |
---|---|---|
1 | proline biosynthetic process (GO:0006561) | 9.16964159 |
2 | proline metabolic process (GO:0006560) | 7.31606623 |
3 | regulation of integrin activation (GO:0033623) | 6.81529357 |
4 | embryonic process involved in female pregnancy (GO:0060136) | 6.67060242 |
5 | transcription from mitochondrial promoter (GO:0006390) | 6.49832344 |
6 | positive regulation of protein homooligomerization (GO:0032464) | 6.40313978 |
7 | replication fork processing (GO:0031297) | 5.72302363 |
8 | regulation of protein homooligomerization (GO:0032462) | 5.72059052 |
9 | oxidative demethylation (GO:0070989) | 5.57297736 |
10 | negative regulation of erythrocyte differentiation (GO:0045647) | 5.36795710 |
11 | establishment of apical/basal cell polarity (GO:0035089) | 4.99429062 |
12 | embryonic placenta development (GO:0001892) | 4.91104070 |
13 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 4.83972465 |
14 | cellular response to ATP (GO:0071318) | 4.82412831 |
15 | response to peptidoglycan (GO:0032494) | 4.77111714 |
16 | poly(A)+ mRNA export from nucleus (GO:0016973) | 4.70451099 |
17 | establishment of monopolar cell polarity (GO:0061162) | 4.61125997 |
18 | establishment or maintenance of monopolar cell polarity (GO:0061339) | 4.61125997 |
19 | glutamine family amino acid biosynthetic process (GO:0009084) | 4.55749276 |
20 | sulfur amino acid catabolic process (GO:0000098) | 4.50807544 |
21 | DNA strand renaturation (GO:0000733) | 4.43880880 |
22 | maintenance of fidelity involved in DNA-dependent DNA replication (GO:0045005) | 4.30798073 |
23 | very-low-density lipoprotein particle assembly (GO:0034379) | 4.27067051 |
24 | mitochondrial DNA metabolic process (GO:0032042) | 4.21215410 |
25 | regulation of vitamin D biosynthetic process (GO:0060556) | 4.20913507 |
26 | negative regulation of protein oligomerization (GO:0032460) | 4.15611336 |
27 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 4.00444442 |
28 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.96151270 |
29 | protein localization to endosome (GO:0036010) | 3.91002450 |
30 | alkaloid metabolic process (GO:0009820) | 3.89266067 |
31 | negative regulation of Ras GTPase activity (GO:0034261) | 3.87110717 |
32 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.84257781 |
33 | regulation of translational fidelity (GO:0006450) | 3.72415987 |
34 | mitotic G1 DNA damage checkpoint (GO:0031571) | 3.70125914 |
35 | regulation of cholesterol homeostasis (GO:2000188) | 3.66622188 |
36 | negative regulation of JAK-STAT cascade (GO:0046426) | 3.65619984 |
37 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 3.63897883 |
38 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 3.63897883 |
39 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.62317073 |
40 | regulation of protein oligomerization (GO:0032459) | 3.62199399 |
41 | response to muramyl dipeptide (GO:0032495) | 3.61954587 |
42 | positive regulation of protein oligomerization (GO:0032461) | 3.61654976 |
43 | stress fiber assembly (GO:0043149) | 3.61466350 |
44 | cell migration in hindbrain (GO:0021535) | 3.54223975 |
45 | mitotic G1/S transition checkpoint (GO:0044819) | 3.51804854 |
46 | cellular response to arsenic-containing substance (GO:0071243) | 3.50395596 |
47 | negative regulation of cell cycle arrest (GO:0071157) | 3.48933589 |
48 | convergent extension (GO:0060026) | 3.47705747 |
49 | glycosphingolipid catabolic process (GO:0046479) | 3.47420481 |
50 | activation of MAPKKK activity (GO:0000185) | 3.47059255 |
51 | regulation of vitamin metabolic process (GO:0030656) | 3.39263874 |
52 | embryonic camera-type eye development (GO:0031076) | 3.39257341 |
53 | anatomical structure regression (GO:0060033) | 3.39053491 |
54 | regulation of protein polyubiquitination (GO:1902914) | 3.37452862 |
55 | mannose metabolic process (GO:0006013) | 3.36055740 |
56 | positive regulation of developmental pigmentation (GO:0048087) | 3.35886532 |
57 | G1 DNA damage checkpoint (GO:0044783) | 3.35480369 |
58 | mRNA cleavage (GO:0006379) | 3.34178005 |
59 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 3.32269543 |
60 | L-ascorbic acid metabolic process (GO:0019852) | 3.31381899 |
61 | response to thyroid hormone (GO:0097066) | 3.31167243 |
62 | apoptotic process involved in morphogenesis (GO:0060561) | 3.27705622 |
63 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.24583386 |
64 | modulation by symbiont of host cellular process (GO:0044068) | 3.22477242 |
65 | positive regulation of receptor recycling (GO:0001921) | 3.21683176 |
66 | heme transport (GO:0015886) | 3.21234264 |
67 | regulation of NFAT protein import into nucleus (GO:0051532) | 3.12350409 |
68 | NIK/NF-kappaB signaling (GO:0038061) | 3.10312855 |
69 | synaptic vesicle endocytosis (GO:0048488) | 3.09075959 |
70 | regulation of hippo signaling (GO:0035330) | 3.07470079 |
71 | germinal center formation (GO:0002467) | 3.07098237 |
72 | negative regulation of fatty acid metabolic process (GO:0045922) | 3.06605241 |
73 | regulation of cell size (GO:0008361) | 3.05036683 |
74 | intestinal cholesterol absorption (GO:0030299) | 3.04452029 |
75 | pinocytosis (GO:0006907) | 3.04164351 |
76 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.03905366 |
77 | glycolipid catabolic process (GO:0019377) | 3.03857560 |
78 | regulation of podosome assembly (GO:0071801) | 3.03318562 |
79 | glial cell migration (GO:0008347) | 3.01125842 |
80 | face development (GO:0060324) | 3.00702161 |
81 | L-phenylalanine metabolic process (GO:0006558) | 2.98634686 |
82 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.98634686 |
83 | negative regulation of heart rate (GO:0010459) | 2.96641762 |
84 | response to laminar fluid shear stress (GO:0034616) | 2.94834965 |
85 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.94026670 |
86 | oligosaccharide catabolic process (GO:0009313) | 2.91893245 |
87 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.91848973 |
88 | mitochondrion transport along microtubule (GO:0047497) | 2.90838565 |
89 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 2.90838565 |
90 | regulation of leukocyte degranulation (GO:0043300) | 2.89848687 |
91 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.87711064 |
92 | acylglycerol homeostasis (GO:0055090) | 2.85097292 |
93 | triglyceride homeostasis (GO:0070328) | 2.85097292 |
94 | histone H4-K12 acetylation (GO:0043983) | 2.84989345 |
95 | low-density lipoprotein particle clearance (GO:0034383) | 2.84664859 |
96 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 2.84565834 |
97 | neuromuscular process controlling posture (GO:0050884) | 2.84437089 |
98 | activation of Rac GTPase activity (GO:0032863) | 2.83725616 |
99 | nodal signaling pathway (GO:0038092) | 2.83414511 |
100 | cellular response to zinc ion (GO:0071294) | 2.83172724 |
101 | plasma lipoprotein particle assembly (GO:0034377) | 2.82600768 |
102 | cholesterol efflux (GO:0033344) | 2.81941597 |
103 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.81086105 |
104 | DNA deamination (GO:0045006) | 2.80523415 |
105 | regulation of mitochondrial depolarization (GO:0051900) | 2.78937772 |
106 | negative regulation of interleukin-12 production (GO:0032695) | 2.77863679 |
107 | regulation of response to reactive oxygen species (GO:1901031) | 2.75757973 |
108 | decidualization (GO:0046697) | 2.75461567 |
109 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.75364262 |
110 | positive regulation by host of viral transcription (GO:0043923) | 2.75242451 |
111 | hypotonic response (GO:0006971) | 2.75183543 |
112 | regulation of mast cell degranulation (GO:0043304) | 2.72526257 |
113 | membrane tubulation (GO:0097320) | 2.72156540 |
114 | macrophage activation involved in immune response (GO:0002281) | 2.69057739 |
115 | positive regulation of T cell apoptotic process (GO:0070234) | 2.67921538 |
116 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.67481021 |
117 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.67481021 |
118 | modulation by symbiont of host immune response (GO:0052553) | 2.67481021 |
119 | positive regulation by symbiont of host defense response (GO:0052509) | 2.67481021 |
120 | modulation by symbiont of host defense response (GO:0052031) | 2.67481021 |
121 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.67481021 |
122 | regulation of chemokine biosynthetic process (GO:0045073) | 2.67169887 |
123 | regulation of early endosome to late endosome transport (GO:2000641) | 2.66145220 |
124 | labyrinthine layer development (GO:0060711) | 2.65464784 |
125 | regulation of intracellular estrogen receptor signaling pathway (GO:0033146) | 2.65422801 |
126 | trophectodermal cell differentiation (GO:0001829) | 2.64752158 |
127 | anterior/posterior axis specification, embryo (GO:0008595) | 2.64077836 |
128 | signal complex assembly (GO:0007172) | 2.62966301 |
129 | neutrophil activation involved in immune response (GO:0002283) | 2.62887969 |
130 | regulation of macrophage chemotaxis (GO:0010758) | 2.62852647 |
131 | regulation of posttranscriptional gene silencing (GO:0060147) | 2.62574180 |
132 | regulation of gene silencing by miRNA (GO:0060964) | 2.62574180 |
133 | regulation of gene silencing by RNA (GO:0060966) | 2.62574180 |
134 | glycogen catabolic process (GO:0005980) | 2.62270951 |
135 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.62194110 |
136 | protein targeting to vacuole (GO:0006623) | 2.62185277 |
137 | protein targeting to lysosome (GO:0006622) | 2.62185277 |
138 | establishment of protein localization to vacuole (GO:0072666) | 2.62185277 |
139 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.61279290 |
140 | barbed-end actin filament capping (GO:0051016) | 2.61033114 |
141 | auditory receptor cell stereocilium organization (GO:0060088) | 2.60649847 |
142 | viral mRNA export from host cell nucleus (GO:0046784) | 2.60032444 |
143 | cellular protein complex localization (GO:0034629) | 2.59889021 |
144 | mRNA transcription (GO:0009299) | 2.59154685 |
145 | glucose 6-phosphate metabolic process (GO:0051156) | 2.59099807 |
146 | negative regulation of appetite (GO:0032099) | 2.58636906 |
147 | negative regulation of response to food (GO:0032096) | 2.58636906 |
148 | modulation by virus of host process (GO:0019054) | 2.57688724 |
149 | Golgi transport vesicle coating (GO:0048200) | 2.56888751 |
150 | COPI coating of Golgi vesicle (GO:0048205) | 2.56888751 |
151 | response to arsenic-containing substance (GO:0046685) | 2.55165491 |
152 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.51197845 |
153 | adherens junction assembly (GO:0034333) | 2.50601248 |
154 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.49981225 |
155 | pentose-phosphate shunt (GO:0006098) | 2.49208338 |
156 | regulation of nucleobase-containing compound transport (GO:0032239) | 2.49040668 |
157 | positive regulation of p38MAPK cascade (GO:1900745) | 2.45984644 |
158 | positive regulation of nuclease activity (GO:0032075) | 2.44551481 |
159 | ceramide catabolic process (GO:0046514) | 2.44382889 |
160 | positive regulation of protein dephosphorylation (GO:0035307) | 2.42474154 |
161 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.42361017 |
162 | positive regulation of leukocyte degranulation (GO:0043302) | 2.42142849 |
163 | T-helper 1 type immune response (GO:0042088) | 2.41315877 |
164 | mitotic chromosome condensation (GO:0007076) | 2.40470128 |
165 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.40253419 |
166 | adenosine receptor signaling pathway (GO:0001973) | 2.39343409 |
167 | hyaluronan catabolic process (GO:0030214) | 2.38980778 |
168 | focal adhesion assembly (GO:0048041) | 2.38379792 |
169 | cell-substrate adherens junction assembly (GO:0007045) | 2.38379792 |
170 | regulation of response to osmotic stress (GO:0047484) | 2.38153094 |
171 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.36551577 |
172 | skin morphogenesis (GO:0043589) | 2.36230712 |
173 | negative regulation of adherens junction organization (GO:1903392) | 2.35070910 |
174 | negative regulation of focal adhesion assembly (GO:0051895) | 2.35070910 |
175 | negative regulation of cell junction assembly (GO:1901889) | 2.35070910 |
176 | epithelial cell-cell adhesion (GO:0090136) | 2.34228007 |
177 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.33864276 |
178 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.32518828 |
179 | mRNA transcription from RNA polymerase II promoter (GO:0042789) | 2.30348454 |
180 | cellular response to lipopolysaccharide (GO:0071222) | 2.29232610 |
181 | cortical actin cytoskeleton organization (GO:0030866) | 2.29062449 |
182 | toll-like receptor 3 signaling pathway (GO:0034138) | 2.28142127 |
183 | myeloid dendritic cell differentiation (GO:0043011) | 2.28103779 |
184 | TRIF-dependent toll-like receptor signaling pathway (GO:0035666) | 2.26969110 |
185 | ER-nucleus signaling pathway (GO:0006984) | 2.26325058 |
186 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.26207791 |
187 | regulation of cholesterol storage (GO:0010885) | 2.26091802 |
188 | regulation of regulated secretory pathway (GO:1903305) | 2.25314039 |
189 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.24995127 |
190 | regulation of RNA export from nucleus (GO:0046831) | 2.24970401 |
191 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 2.23448187 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.68379171 |
2 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 3.31704427 |
3 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 3.31638594 |
4 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 3.31638594 |
5 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 3.31638594 |
6 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 3.18557964 |
7 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.79423487 |
8 | * SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 2.67223856 |
9 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.54605179 |
10 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 2.49798094 |
11 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.48716410 |
12 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.43055260 |
13 | * FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.40711798 |
14 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.30665236 |
15 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.29026358 |
16 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 2.27867245 |
17 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.27359950 |
18 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.24662313 |
19 | * ERG_21242973_ChIP-ChIP_JURKAT_Human | 2.22386131 |
20 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.16724032 |
21 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.16703079 |
22 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 2.15763681 |
23 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.12282275 |
24 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 2.08759510 |
25 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.02369405 |
26 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.02050519 |
27 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.99772528 |
28 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.99335618 |
29 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.95587703 |
30 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.95114557 |
31 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 1.93988952 |
32 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.90693118 |
33 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.90616661 |
34 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.87837843 |
35 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.83538401 |
36 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.81970694 |
37 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.80545559 |
38 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.79220394 |
39 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.78526480 |
40 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.76182243 |
41 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.75325973 |
42 | KDM2B_26808549_Chip-Seq_K562_Human | 1.73264330 |
43 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.73099022 |
44 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.71733315 |
45 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.68201705 |
46 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.67926746 |
47 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.67211028 |
48 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.66212346 |
49 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.64973227 |
50 | GATA1_19941826_ChIP-Seq_K562_Human | 1.63739498 |
51 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.62613587 |
52 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.59953665 |
53 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.59595676 |
54 | NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 1.57599735 |
55 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.56566351 |
56 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.55567584 |
57 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.54998628 |
58 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.54924718 |
59 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.54720530 |
60 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.54683725 |
61 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.53512095 |
62 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.52511407 |
63 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.51938359 |
64 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.51617188 |
65 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.50647697 |
66 | MAF_26560356_Chip-Seq_TH1_Human | 1.50258282 |
67 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.49550460 |
68 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.48705839 |
69 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.48025291 |
70 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.47667757 |
71 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.45922289 |
72 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.44435750 |
73 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.43988465 |
74 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.42158084 |
75 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.37839231 |
76 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.37599897 |
77 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.36298604 |
78 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.35965359 |
79 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.35062915 |
80 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.34744775 |
81 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.33620903 |
82 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.31494564 |
83 | MYC_22102868_ChIP-Seq_BL_Human | 1.31472174 |
84 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.29073918 |
85 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.28902085 |
86 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.28868017 |
87 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.28724531 |
88 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.28154833 |
89 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.27936320 |
90 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 1.26248416 |
91 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.24885997 |
92 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.24793709 |
93 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.24548755 |
94 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 1.23832933 |
95 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.23698416 |
96 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.23544822 |
97 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.22431652 |
98 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.22039383 |
99 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.21222454 |
100 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.21085761 |
101 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.20903324 |
102 | NANOG_18692474_ChIP-Seq_MESCs_Mouse | 1.20206371 |
103 | UTX_26944678_Chip-Seq_JUKART_Human | 1.19103818 |
104 | MAF_26560356_Chip-Seq_TH2_Human | 1.18772412 |
105 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.17964629 |
106 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.17447998 |
107 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.17076342 |
108 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.15944499 |
109 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.15758470 |
110 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.15550843 |
111 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.15519745 |
112 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 1.14504952 |
113 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.14456654 |
114 | POU5F1_18692474_ChIP-Seq_MESCs_Mouse | 1.14157567 |
115 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.13806435 |
116 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.12249561 |
117 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.10826509 |
118 | NANOG_16518401_ChIP-PET_MESCs_Mouse | 1.09577928 |
119 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.09026692 |
120 | SOX2_18692474_ChIP-Seq_MESCs_Mouse | 1.08545952 |
121 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 1.08042736 |
122 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.07385821 |
123 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 1.06916949 |
124 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.06787214 |
125 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.06719610 |
126 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.04982038 |
127 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.04419667 |
128 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.03242926 |
129 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.03177454 |
130 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.02027831 |
131 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.01992196 |
132 | TCF3_18347094_ChIP-ChIP_MESCs_Mouse | 1.01899846 |
133 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.01628003 |
134 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.01239309 |
135 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 1.01212605 |
136 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.00789789 |
137 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.00065557 |
138 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.00022341 |
139 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.99840765 |
140 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.99489790 |
141 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.98963367 |
142 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.98885164 |
143 | GATA2_19941826_ChIP-Seq_K562_Human | 0.98747435 |
144 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.98463838 |
145 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.97876604 |
146 | P68_20966046_ChIP-Seq_HELA_Human | 0.96515161 |
147 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.96154446 |
148 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.96064122 |
149 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.95803672 |
150 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 0.95535312 |
151 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.95417880 |
152 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.95128797 |
153 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.94836591 |
154 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.94512995 |
155 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.93463177 |
156 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.93401632 |
157 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.92561545 |
158 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.90503180 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0008057_abnormal_DNA_replication | 4.82057448 |
2 | MP0009278_abnormal_bone_marrow | 4.68707791 |
3 | MP0005171_absent_coat_pigmentation | 3.62218749 |
4 | MP0005451_abnormal_body_composition | 3.57413436 |
5 | MP0005085_abnormal_gallbladder_physiolo | 3.43415758 |
6 | MP0005365_abnormal_bile_salt | 3.14853949 |
7 | MP0003172_abnormal_lysosome_physiology | 3.01838945 |
8 | MP0003436_decreased_susceptibility_to | 2.81390123 |
9 | MP0005058_abnormal_lysosome_morphology | 2.61334475 |
10 | MP0002139_abnormal_hepatobiliary_system | 2.56632366 |
11 | MP0010030_abnormal_orbit_morphology | 2.53214935 |
12 | MP0003453_abnormal_keratinocyte_physiol | 2.44678021 |
13 | MP0004233_abnormal_muscle_weight | 2.42243716 |
14 | MP0003890_abnormal_embryonic-extraembry | 2.31137002 |
15 | MP0003283_abnormal_digestive_organ | 2.27533092 |
16 | MP0003300_gastrointestinal_ulcer | 2.24168797 |
17 | MP0005360_urolithiasis | 2.19674935 |
18 | MP0002653_abnormal_ependyma_morphology | 2.06455919 |
19 | MP0004947_skin_inflammation | 2.04788893 |
20 | MP0008260_abnormal_autophagy | 2.02026010 |
21 | MP0010352_gastrointestinal_tract_polyps | 2.01210760 |
22 | MP0005076_abnormal_cell_differentiation | 1.99383275 |
23 | MP0004133_heterotaxia | 1.95117936 |
24 | MP0005397_hematopoietic_system_phenotyp | 1.94274499 |
25 | MP0001545_abnormal_hematopoietic_system | 1.94274499 |
26 | MP0005174_abnormal_tail_pigmentation | 1.93106393 |
27 | * MP0003656_abnormal_erythrocyte_physiolo | 1.88474797 |
28 | MP0003091_abnormal_cell_migration | 1.84731163 |
29 | MP0002009_preneoplasia | 1.82060989 |
30 | MP0000858_altered_metastatic_potential | 1.76397433 |
31 | MP0002419_abnormal_innate_immunity | 1.76009793 |
32 | MP0002269_muscular_atrophy | 1.71795624 |
33 | MP0002998_abnormal_bone_remodeling | 1.70740591 |
34 | MP0002148_abnormal_hypersensitivity_rea | 1.63985267 |
35 | MP0003705_abnormal_hypodermis_morpholog | 1.62412410 |
36 | MP0004808_abnormal_hematopoietic_stem | 1.60933163 |
37 | MP0009840_abnormal_foam_cell | 1.58667667 |
38 | MP0002332_abnormal_exercise_endurance | 1.57618359 |
39 | MP0003045_fibrosis | 1.53331817 |
40 | MP0000579_abnormal_nail_morphology | 1.51275125 |
41 | MP0004264_abnormal_extraembryonic_tissu | 1.51138098 |
42 | MP0003191_abnormal_cellular_cholesterol | 1.50104545 |
43 | MP0000639_abnormal_adrenal_gland | 1.49368585 |
44 | MP0005000_abnormal_immune_tolerance | 1.48679781 |
45 | MP0002249_abnormal_larynx_morphology | 1.47407453 |
46 | MP0001849_ear_inflammation | 1.47264764 |
47 | MP0001853_heart_inflammation | 1.44115114 |
48 | MP0000371_diluted_coat_color | 1.43238093 |
49 | MP0003119_abnormal_digestive_system | 1.41018355 |
50 | MP0009785_altered_susceptibility_to | 1.38967645 |
51 | MP0003075_altered_response_to | 1.36535669 |
52 | MP0001533_abnormal_skeleton_physiology | 1.33073257 |
53 | MP0008438_abnormal_cutaneous_collagen | 1.33072707 |
54 | MP0005025_abnormal_response_to | 1.32158821 |
55 | MP0005409_darkened_coat_color | 1.30522987 |
56 | MP0000604_amyloidosis | 1.30511771 |
57 | MP0005666_abnormal_adipose_tissue | 1.30377559 |
58 | MP0004858_abnormal_nervous_system | 1.29556420 |
59 | MP0002086_abnormal_extraembryonic_tissu | 1.28984325 |
60 | MP0000015_abnormal_ear_pigmentation | 1.28560541 |
61 | MP0003448_altered_tumor_morphology | 1.26817800 |
62 | MP0010234_abnormal_vibrissa_follicle | 1.26336634 |
63 | MP0006082_CNS_inflammation | 1.26174581 |
64 | MP0009333_abnormal_splenocyte_physiolog | 1.24888046 |
65 | MP0004019_abnormal_vitamin_homeostasis | 1.23295904 |
66 | MP0008875_abnormal_xenobiotic_pharmacok | 1.23072184 |
67 | MP0003566_abnormal_cell_adhesion | 1.21758814 |
68 | MP0005083_abnormal_biliary_tract | 1.21531023 |
69 | MP0004197_abnormal_fetal_growth/weight/ | 1.20979943 |
70 | MP0003329_amyloid_beta_deposits | 1.20604284 |
71 | MP0008995_early_reproductive_senescence | 1.18970938 |
72 | MP0002282_abnormal_trachea_morphology | 1.16410595 |
73 | MP0000685_abnormal_immune_system | 1.14440630 |
74 | MP0003806_abnormal_nucleotide_metabolis | 1.14312802 |
75 | MP0005266_abnormal_metabolism | 1.14112905 |
76 | MP0010329_abnormal_lipoprotein_level | 1.14091758 |
77 | MP0000609_abnormal_liver_physiology | 1.13971905 |
78 | MP0005257_abnormal_intraocular_pressure | 1.13920265 |
79 | MP0002796_impaired_skin_barrier | 1.13250409 |
80 | MP0001835_abnormal_antigen_presentation | 1.11115932 |
81 | MP0000678_abnormal_parathyroid_gland | 1.08967758 |
82 | MP0005375_adipose_tissue_phenotype | 1.08917572 |
83 | MP0002452_abnormal_antigen_presenting | 1.08815113 |
84 | MP0008004_abnormal_stomach_pH | 1.08503973 |
85 | MP0009764_decreased_sensitivity_to | 1.07393690 |
86 | MP0009115_abnormal_fat_cell | 1.07370684 |
87 | MP0000747_muscle_weakness | 1.06510180 |
88 | MP0005387_immune_system_phenotype | 1.06403472 |
89 | MP0001790_abnormal_immune_system | 1.06403472 |
90 | MP0002733_abnormal_thermal_nociception | 1.02884170 |
91 | MP0000733_abnormal_muscle_development | 1.01021061 |
92 | MP0002723_abnormal_immune_serum | 0.99871712 |
93 | MP0002118_abnormal_lipid_homeostasis | 0.99523302 |
94 | MP0005621_abnormal_cell_physiology | 0.99422904 |
95 | MP0005332_abnormal_amino_acid | 0.98885876 |
96 | MP0004130_abnormal_muscle_cell | 0.98239469 |
97 | MP0001293_anophthalmia | 0.96089604 |
98 | MP0001340_abnormal_eyelid_morphology | 0.95984963 |
99 | MP0003303_peritoneal_inflammation | 0.95362103 |
100 | MP0000751_myopathy | 0.95239134 |
101 | MP0001915_intracranial_hemorrhage | 0.95130878 |
102 | MP0002084_abnormal_developmental_patter | 0.94194957 |
103 | MP0001348_abnormal_lacrimal_gland | 0.94030254 |
104 | MP0005319_abnormal_enzyme/_coenzyme | 0.93677294 |
105 | MP0008874_decreased_physiological_sensi | 0.92201923 |
106 | MP0005166_decreased_susceptibility_to | 0.92117228 |
107 | MP0001324_abnormal_eye_pigmentation | 0.91694643 |
108 | MP0005167_abnormal_blood-brain_barrier | 0.91308052 |
109 | MP0002254_reproductive_system_inflammat | 0.90136065 |
110 | MP0002735_abnormal_chemical_nociception | 0.89675719 |
111 | MP0001819_abnormal_immune_cell | 0.88203913 |
112 | MP0001845_abnormal_inflammatory_respons | 0.87944262 |
113 | MP0002420_abnormal_adaptive_immunity | 0.87819374 |
114 | MP0008469_abnormal_protein_level | 0.87166790 |
115 | MP0000470_abnormal_stomach_morphology | 0.87130559 |
116 | MP0010155_abnormal_intestine_physiology | 0.86702421 |
117 | MP0003828_pulmonary_edema | 0.85720471 |
118 | MP0001697_abnormal_embryo_size | 0.84920262 |
119 | MP0005075_abnormal_melanosome_morpholog | 0.84843153 |
120 | MP0002971_abnormal_brown_adipose | 0.84237562 |
121 | * MP0002398_abnormal_bone_marrow | 0.82945821 |
122 | MP0002111_abnormal_tail_morphology | 0.82538156 |
123 | MP0002060_abnormal_skin_morphology | 0.82326535 |
124 | MP0000598_abnormal_liver_morphology | 0.82023421 |
125 | MP0003252_abnormal_bile_duct | 0.81622098 |
126 | MP0004510_myositis | 0.81434212 |
127 | MP0003690_abnormal_glial_cell | 0.80786149 |
128 | MP0001672_abnormal_embryogenesis/_devel | 0.80414571 |
129 | MP0005380_embryogenesis_phenotype | 0.80414571 |
130 | MP0001730_embryonic_growth_arrest | 0.79899608 |
131 | MP0010630_abnormal_cardiac_muscle | 0.79497985 |
132 | MP0006072_abnormal_retinal_apoptosis | 0.79492578 |
133 | MP0002089_abnormal_postnatal_growth/wei | 0.79289849 |
134 | MP0005376_homeostasis/metabolism_phenot | 0.79056231 |
135 | MP0002085_abnormal_embryonic_tissue | 0.78236125 |
136 | MP0005464_abnormal_platelet_physiology | 0.78165109 |
137 | MP0001970_abnormal_pain_threshold | 0.77712253 |
138 | MP0003221_abnormal_cardiomyocyte_apopto | 0.76857821 |
139 | MP0000955_abnormal_spinal_cord | 0.76228557 |
140 | MP0000759_abnormal_skeletal_muscle | 0.75852858 |
141 | MP0005310_abnormal_salivary_gland | 0.74720613 |
142 | * MP0002429_abnormal_blood_cell | 0.74389034 |
143 | MP0002168_other_aberrant_phenotype | 0.73471815 |
144 | MP0002970_abnormal_white_adipose | 0.73393797 |
145 | MP0005390_skeleton_phenotype | 0.73137405 |
146 | MP0005165_increased_susceptibility_to | 0.73005797 |
147 | MP0003795_abnormal_bone_structure | 0.72798912 |
148 | MP0000716_abnormal_immune_system | 0.72689292 |
149 | MP0000350_abnormal_cell_proliferation | 0.71997545 |
150 | MP0003279_aneurysm | 0.71607478 |
151 | MP0003111_abnormal_nucleus_morphology | 0.71581567 |
152 | MP0005164_abnormal_response_to | 0.70764528 |
153 | MP0000920_abnormal_myelination | 0.69946462 |
154 | MP0003567_abnormal_fetal_cardiomyocyte | 0.69701098 |
155 | MP0005384_cellular_phenotype | 0.68625280 |
156 | MP0002697_abnormal_eye_size | 0.68514895 |
157 | MP0009931_abnormal_skin_appearance | 0.68469148 |
158 | MP0003755_abnormal_palate_morphology | 0.68464066 |
159 | MP0002877_abnormal_melanocyte_morpholog | 0.67888318 |
160 | MP0003633_abnormal_nervous_system | 0.67286688 |
161 | MP0003634_abnormal_glial_cell | 0.66786755 |
162 | MP0002405_respiratory_system_inflammati | 0.66561962 |
163 | MP0000762_abnormal_tongue_morphology | 0.65989817 |
164 | MP0003137_abnormal_impulse_conducting | 0.65306948 |
165 | MP0003935_abnormal_craniofacial_develop | 0.64899361 |
166 | MP0000343_altered_response_to | 0.64454695 |
167 | MP0005023_abnormal_wound_healing | 0.64029626 |
168 | MP0004185_abnormal_adipocyte_glucose | 0.64021834 |
169 | MP0010307_abnormal_tumor_latency | 0.63962080 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Hypochromic microcytic anemia (HP:0004840) | 5.86869982 |
2 | Turricephaly (HP:0000262) | 5.79449907 |
3 | Rib fusion (HP:0000902) | 4.97743217 |
4 | Pustule (HP:0200039) | 4.49422884 |
5 | Alopecia of scalp (HP:0002293) | 4.43464586 |
6 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.19049484 |
7 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.19049484 |
8 | Abnormality of glycolipid metabolism (HP:0010969) | 4.19049484 |
9 | Ulnar bowing (HP:0003031) | 4.17734818 |
10 | Annular pancreas (HP:0001734) | 4.08614100 |
11 | Rectovaginal fistula (HP:0000143) | 4.00304386 |
12 | Rectal fistula (HP:0100590) | 4.00304386 |
13 | Intestinal fistula (HP:0100819) | 3.97570409 |
14 | Vaginal fistula (HP:0004320) | 3.91345221 |
15 | Concave nail (HP:0001598) | 3.77106677 |
16 | Increased IgM level (HP:0003496) | 3.74947183 |
17 | Increased cerebral lipofuscin (HP:0011813) | 3.46633211 |
18 | Facial hemangioma (HP:0000329) | 3.45953772 |
19 | Coronal craniosynostosis (HP:0004440) | 3.35063719 |
20 | Mucopolysacchariduria (HP:0008155) | 3.29497677 |
21 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.29497677 |
22 | Orthostatic hypotension (HP:0001278) | 3.26741998 |
23 | Tongue fasciculations (HP:0001308) | 3.12819328 |
24 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.05193204 |
25 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.05193204 |
26 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.05193204 |
27 | Dysautonomia (HP:0002459) | 3.02263223 |
28 | Short humerus (HP:0005792) | 3.01720885 |
29 | Muscle fibrillation (HP:0010546) | 3.00693967 |
30 | Myocardial infarction (HP:0001658) | 3.00297942 |
31 | Neurofibrillary tangles (HP:0002185) | 2.99832971 |
32 | Nuclear cataract (HP:0100018) | 2.99499735 |
33 | Dysostosis multiplex (HP:0000943) | 2.94908908 |
34 | Distal lower limb amyotrophy (HP:0008944) | 2.91224422 |
35 | Cerebral inclusion bodies (HP:0100314) | 2.89463751 |
36 | Poikiloderma (HP:0001029) | 2.88003857 |
37 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.86859178 |
38 | Abnormality of macrophages (HP:0004311) | 2.82758669 |
39 | Diaphragmatic weakness (HP:0009113) | 2.79229185 |
40 | Abnormality of the aortic arch (HP:0012303) | 2.77513343 |
41 | Vertebral compression fractures (HP:0002953) | 2.76549629 |
42 | Hyperacusis (HP:0010780) | 2.76073088 |
43 | Achilles tendon contracture (HP:0001771) | 2.75720842 |
44 | Aplasia/hypoplasia of the humerus (HP:0006507) | 2.74083597 |
45 | Abnormality of the lower motor neuron (HP:0002366) | 2.73803197 |
46 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.71162175 |
47 | Clumsiness (HP:0002312) | 2.70335495 |
48 | Male infertility (HP:0003251) | 2.65951843 |
49 | Loss of speech (HP:0002371) | 2.65275724 |
50 | Hypochromic anemia (HP:0001931) | 2.64219404 |
51 | Abnormal hemoglobin (HP:0011902) | 2.60658743 |
52 | Hypokinesia (HP:0002375) | 2.59910897 |
53 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 2.57372188 |
54 | Alacrima (HP:0000522) | 2.57025689 |
55 | Vacuolated lymphocytes (HP:0001922) | 2.56000814 |
56 | Congenital hip dislocation (HP:0001374) | 2.54766403 |
57 | Cerebral aneurysm (HP:0004944) | 2.54719733 |
58 | Increased connective tissue (HP:0009025) | 2.54433158 |
59 | Large for gestational age (HP:0001520) | 2.54333700 |
60 | Abnormality of the Achilles tendon (HP:0005109) | 2.52379569 |
61 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 2.50649468 |
62 | Vertebral hypoplasia (HP:0008417) | 2.50649468 |
63 | Lower limb hyperreflexia (HP:0002395) | 2.48109859 |
64 | Hamartoma (HP:0010566) | 2.46008893 |
65 | Polycythemia (HP:0001901) | 2.45621775 |
66 | Reticulocytosis (HP:0001923) | 2.40891421 |
67 | Asymmetric septal hypertrophy (HP:0001670) | 2.40555467 |
68 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.39141210 |
69 | Neuronal loss in central nervous system (HP:0002529) | 2.37445668 |
70 | Bowing of the arm (HP:0006488) | 2.37081127 |
71 | Bowed forearm bones (HP:0003956) | 2.37081127 |
72 | Short chin (HP:0000331) | 2.34278134 |
73 | Anteriorly placed anus (HP:0001545) | 2.34224257 |
74 | Growth hormone excess (HP:0000845) | 2.32043517 |
75 | Albinism (HP:0001022) | 2.30572238 |
76 | Distal lower limb muscle weakness (HP:0009053) | 2.30428270 |
77 | Upper limb amyotrophy (HP:0009129) | 2.28662546 |
78 | Distal upper limb amyotrophy (HP:0007149) | 2.28662546 |
79 | Deep venous thrombosis (HP:0002625) | 2.28481206 |
80 | Choanal stenosis (HP:0000452) | 2.26625172 |
81 | Intestinal atresia (HP:0011100) | 2.25873467 |
82 | Insomnia (HP:0100785) | 2.25176107 |
83 | Protrusio acetabuli (HP:0003179) | 2.24904262 |
84 | Abnormality of male internal genitalia (HP:0000022) | 2.24727956 |
85 | Diminished movement (HP:0002374) | 2.24538718 |
86 | Thin bony cortex (HP:0002753) | 2.23597231 |
87 | Broad face (HP:0000283) | 2.23131431 |
88 | Premature rupture of membranes (HP:0001788) | 2.23010428 |
89 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.22062258 |
90 | Apathy (HP:0000741) | 2.21366742 |
91 | Hypobetalipoproteinemia (HP:0003563) | 2.20822172 |
92 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.18872750 |
93 | Lower limb amyotrophy (HP:0007210) | 2.17652370 |
94 | Bilateral sensorineural hearing impairment (HP:0008619) | 2.14741676 |
95 | Supranuclear gaze palsy (HP:0000605) | 2.13939614 |
96 | Intrahepatic cholestasis (HP:0001406) | 2.12617376 |
97 | Hypertensive crisis (HP:0100735) | 2.12340105 |
98 | Increased serum ferritin (HP:0003281) | 2.12192853 |
99 | Xanthomatosis (HP:0000991) | 2.10249068 |
100 | Vertebral fusion (HP:0002948) | 2.09974307 |
101 | Obstructive sleep apnea (HP:0002870) | 2.09206945 |
102 | Diminished motivation (HP:0000745) | 2.09033612 |
103 | Broad alveolar ridges (HP:0000187) | 2.08699459 |
104 | Hypotrichosis (HP:0001006) | 2.05099834 |
105 | Coarse hair (HP:0002208) | 2.03686395 |
106 | Joint stiffness (HP:0001387) | 2.03149635 |
107 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.02351254 |
108 | Slow saccadic eye movements (HP:0000514) | 2.00702106 |
109 | Thoracic kyphosis (HP:0002942) | 1.97359112 |
110 | Hyperparathyroidism (HP:0000843) | 1.96569154 |
111 | Abnormality of the thoracic spine (HP:0100711) | 1.96263632 |
112 | Eczematoid dermatitis (HP:0000976) | 1.96076042 |
113 | Ankyloglossia (HP:0010296) | 1.95908105 |
114 | Disinhibition (HP:0000734) | 1.95688263 |
115 | Aplasia of the musculature (HP:0100854) | 1.95560444 |
116 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.94388556 |
117 | Fatigue (HP:0012378) | 1.93832988 |
118 | Abnormality of complement system (HP:0005339) | 1.93458981 |
119 | Increased CSF protein (HP:0002922) | 1.92129039 |
120 | Abnormality of the periventricular white matter (HP:0002518) | 1.91911787 |
121 | Difficulty climbing stairs (HP:0003551) | 1.91647921 |
122 | Premature skin wrinkling (HP:0100678) | 1.91502633 |
123 | Complement deficiency (HP:0004431) | 1.91488752 |
124 | Abnormality of the astrocytes (HP:0100707) | 1.91391780 |
125 | Astrocytoma (HP:0009592) | 1.91391780 |
126 | Generalized amyotrophy (HP:0003700) | 1.91206966 |
127 | Bifid uvula (HP:0000193) | 1.90283368 |
128 | Long palpebral fissure (HP:0000637) | 1.90178540 |
129 | Atonic seizures (HP:0010819) | 1.89348786 |
130 | Decreased lacrimation (HP:0000633) | 1.87905084 |
131 | Squamous cell carcinoma (HP:0002860) | 1.87615727 |
132 | Upper motor neuron abnormality (HP:0002127) | 1.86253869 |
133 | Recurrent bacterial skin infections (HP:0005406) | 1.85976642 |
134 | Tetraparesis (HP:0002273) | 1.85043353 |
135 | Status epilepticus (HP:0002133) | 1.84429807 |
136 | Fetal akinesia sequence (HP:0001989) | 1.83764797 |
137 | Interstitial pulmonary disease (HP:0006530) | 1.83659838 |
138 | Abnormal gallbladder physiology (HP:0012438) | 1.83442266 |
139 | Cholecystitis (HP:0001082) | 1.83442266 |
140 | Recurrent abscess formation (HP:0002722) | 1.83028133 |
141 | Axonal loss (HP:0003447) | 1.82674770 |
142 | Bone pain (HP:0002653) | 1.82627746 |
143 | Cheilitis (HP:0100825) | 1.81858948 |
144 | Peripheral hypomyelination (HP:0007182) | 1.81705163 |
145 | Popliteal pterygium (HP:0009756) | 1.81550167 |
146 | Amyloidosis (HP:0011034) | 1.81466144 |
147 | Abnormal large intestine physiology (HP:0012700) | 1.81223766 |
148 | Narrow nasal bridge (HP:0000446) | 1.79714871 |
149 | Generalized hyperpigmentation (HP:0007440) | 1.78987231 |
150 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.78551559 |
151 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.78551559 |
152 | Purpura (HP:0000979) | 1.77710120 |
153 | Joint hemorrhage (HP:0005261) | 1.76912798 |
154 | Hypercortisolism (HP:0001578) | 1.76903579 |
155 | Split hand (HP:0001171) | 1.76811266 |
156 | Upper limb muscle weakness (HP:0003484) | 1.76475563 |
157 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.76081085 |
158 | Decreased motor nerve conduction velocity (HP:0003431) | 1.75669538 |
159 | Ketoacidosis (HP:0001993) | 1.75232132 |
160 | Petechiae (HP:0000967) | 1.75213092 |
161 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.74711433 |
162 | Spondylolisthesis (HP:0003302) | 1.74588680 |
163 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.74453497 |
164 | Exercise-induced myalgia (HP:0003738) | 1.74432615 |
165 | Cellulitis (HP:0100658) | 1.72607144 |
166 | Hand muscle atrophy (HP:0009130) | 1.71773883 |
167 | Spinal rigidity (HP:0003306) | 1.71732489 |
168 | Disproportionate tall stature (HP:0001519) | 1.71654872 |
169 | Bowel incontinence (HP:0002607) | 1.71426226 |
170 | Systemic lupus erythematosus (HP:0002725) | 1.68749258 |
171 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.68588574 |
172 | Increased variability in muscle fiber diameter (HP:0003557) | 1.65619967 |
173 | Genu recurvatum (HP:0002816) | 1.63566425 |
174 | J-shaped sella turcica (HP:0002680) | 1.62220628 |
175 | Pathologic fracture (HP:0002756) | 1.59955352 |
176 | Dysmetric saccades (HP:0000641) | 1.59249477 |
177 | Abnormality of oral frenula (HP:0000190) | 1.58973873 |
178 | Mitral regurgitation (HP:0001653) | 1.58104042 |
179 | Impaired platelet aggregation (HP:0003540) | 1.58056630 |
180 | Abnormal platelet function (HP:0011869) | 1.58056630 |
181 | Cervical subluxation (HP:0003308) | 1.57412895 |
182 | Hemorrhage of the eye (HP:0011885) | 1.53801458 |
183 | Personality changes (HP:0000751) | 1.52388045 |
184 | Mutism (HP:0002300) | 1.52297029 |
185 | Truncus arteriosus (HP:0001660) | 1.50896299 |
186 | Polygenic inheritance (HP:0010982) | 1.49995616 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ICK | 5.03384947 |
2 | DDR2 | 4.44670106 |
3 | MAPK15 | 4.17132634 |
4 | MAP3K6 | 4.15793703 |
5 | MAP3K11 | 3.18173835 |
6 | FGR | 3.04006111 |
7 | TYRO3 | 2.97083862 |
8 | MATK | 2.87379490 |
9 | PINK1 | 2.86130039 |
10 | BMX | 2.47487893 |
11 | DAPK1 | 2.42677707 |
12 | NME2 | 2.38536979 |
13 | PDGFRA | 2.19358442 |
14 | PIM2 | 2.08358158 |
15 | UHMK1 | 2.06507116 |
16 | RIPK4 | 2.05254249 |
17 | YES1 | 2.03887991 |
18 | MAP3K14 | 1.99642021 |
19 | PRKD2 | 1.95789303 |
20 | CSK | 1.95039323 |
21 | EEF2K | 1.94666757 |
22 | AKT3 | 1.87221627 |
23 | MAP3K13 | 1.78672388 |
24 | SMG1 | 1.78508916 |
25 | PRPF4B | 1.76024981 |
26 | LATS2 | 1.57996737 |
27 | DYRK1B | 1.51015343 |
28 | MAP3K3 | 1.49780844 |
29 | TRPM7 | 1.47357990 |
30 | TBK1 | 1.46404496 |
31 | CDK12 | 1.44554004 |
32 | MAP3K1 | 1.35732775 |
33 | RPS6KC1 | 1.33836355 |
34 | RPS6KL1 | 1.33836355 |
35 | GSK3A | 1.30725386 |
36 | PHKG1 | 1.30624360 |
37 | PHKG2 | 1.30624360 |
38 | MOS | 1.25943381 |
39 | ARAF | 1.25179891 |
40 | IRAK2 | 1.24156450 |
41 | IRAK4 | 1.21575979 |
42 | CDK6 | 1.19668843 |
43 | RPS6KA6 | 1.17656410 |
44 | ERN1 | 1.15121622 |
45 | PIM1 | 1.13943543 |
46 | MAP3K9 | 1.11952836 |
47 | DAPK2 | 1.11723425 |
48 | TRIB3 | 1.06638734 |
49 | CDK7 | 1.06608530 |
50 | BRAF | 1.05155241 |
51 | CDC42BPA | 1.02856370 |
52 | PAK4 | 1.00303073 |
53 | SIK2 | 0.98313775 |
54 | ZAP70 | 0.92760904 |
55 | MAP3K8 | 0.91272129 |
56 | RIPK1 | 0.91046383 |
57 | HIPK2 | 0.89023379 |
58 | EPHA2 | 0.88327432 |
59 | MST1R | 0.86961714 |
60 | PDPK1 | 0.84123505 |
61 | ABL2 | 0.82675874 |
62 | MAPK11 | 0.82408137 |
63 | MTOR | 0.82323659 |
64 | TAOK2 | 0.81339473 |
65 | CAMK1D | 0.80144698 |
66 | ALK | 0.77874305 |
67 | EPHB1 | 0.76276476 |
68 | PRKAA1 | 0.72242177 |
69 | ERBB4 | 0.71896363 |
70 | RPS6KA1 | 0.69747890 |
71 | TYK2 | 0.69531119 |
72 | TESK1 | 0.68919293 |
73 | TAOK1 | 0.67098239 |
74 | CDK4 | 0.66369314 |
75 | BRD4 | 0.65539222 |
76 | CLK1 | 0.64771574 |
77 | CAMK1G | 0.64329467 |
78 | MAP3K10 | 0.63183941 |
79 | PDGFRB | 0.62932215 |
80 | BMPR2 | 0.61697625 |
81 | SIK1 | 0.61648985 |
82 | RAF1 | 0.60469232 |
83 | BLK | 0.59412696 |
84 | PTK2 | 0.58869154 |
85 | EGFR | 0.56203285 |
86 | MAP2K4 | 0.53935948 |
87 | NTRK1 | 0.53876113 |
88 | SGK1 | 0.53647592 |
89 | MAP3K2 | 0.53427244 |
90 | MAPK12 | 0.51982948 |
91 | PRKG2 | 0.48939822 |
92 | PAK2 | 0.48710683 |
93 | GRK5 | 0.48639107 |
94 | SIK3 | 0.48631709 |
95 | MAP4K1 | 0.48062486 |
96 | PAK6 | 0.47896672 |
97 | STK24 | 0.47554305 |
98 | MAPK10 | 0.47548691 |
99 | SGK3 | 0.47441752 |
100 | IRAK1 | 0.47347515 |
101 | PDK1 | 0.45712914 |
102 | STK3 | 0.44488223 |
103 | JAK3 | 0.43992818 |
104 | KSR1 | 0.43231003 |
105 | PTK6 | 0.41146880 |
106 | RPS6KB1 | 0.40564188 |
107 | PRKAA2 | 0.40187828 |
108 | JAK2 | 0.39354626 |
109 | MAPK4 | 0.38262395 |
110 | IKBKB | 0.36648099 |
111 | PRKCZ | 0.36634694 |
112 | MAPK1 | 0.36144497 |
113 | STK38 | 0.34693667 |
114 | NEK9 | 0.34044022 |
115 | DYRK2 | 0.33840278 |
116 | MAP3K5 | 0.33800054 |
117 | IKBKE | 0.33245963 |
118 | GRK7 | 0.33238459 |
119 | MAPK3 | 0.31977866 |
120 | ERBB3 | 0.31928741 |
121 | RPS6KA3 | 0.31851483 |
122 | TGFBR2 | 0.31102036 |
123 | TAOK3 | 0.30868186 |
124 | DMPK | 0.30645740 |
125 | CHUK | 0.29768575 |
126 | CAMK2G | 0.29609838 |
127 | MAP2K3 | 0.28256782 |
128 | MAPK14 | 0.27580979 |
129 | CHEK2 | 0.26980769 |
130 | IRAK3 | 0.26695633 |
131 | MARK2 | 0.26306244 |
132 | NTRK2 | 0.25162213 |
133 | PRKACG | 0.24964581 |
134 | MAPKAPK2 | 0.24660342 |
135 | CDK2 | 0.24367937 |
136 | RPS6KA2 | 0.23807399 |
137 | INSR | 0.22974030 |
138 | KSR2 | 0.22406297 |
139 | FGFR4 | 0.21517080 |
140 | CAMK4 | 0.21328576 |
141 | ABL1 | 0.21226742 |
142 | TNK2 | 0.20228286 |
143 | LYN | 0.19942915 |
144 | CAMK2A | 0.19096159 |
145 | MET | 0.18883382 |
146 | TTN | 0.18080776 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 5.10976896 |
2 | Other glycan degradation_Homo sapiens_hsa00511 | 3.19793240 |
3 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.98275537 |
4 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.96237893 |
5 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.47986176 |
6 | mTOR signaling pathway_Homo sapiens_hsa04150 | 2.27982342 |
7 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.21162800 |
8 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.19990929 |
9 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.09158111 |
10 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.04833560 |
11 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 2.02339612 |
12 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.96296506 |
13 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.95582070 |
14 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.90811211 |
15 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.86563432 |
16 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.82793837 |
17 | Lysine degradation_Homo sapiens_hsa00310 | 1.76851323 |
18 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.74534366 |
19 | Sulfur relay system_Homo sapiens_hsa04122 | 1.69727048 |
20 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.63025221 |
21 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.63011555 |
22 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.61302291 |
23 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.58611087 |
24 | Base excision repair_Homo sapiens_hsa03410 | 1.56136302 |
25 | Leishmaniasis_Homo sapiens_hsa05140 | 1.56045570 |
26 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.54826339 |
27 | Bladder cancer_Homo sapiens_hsa05219 | 1.54154826 |
28 | Malaria_Homo sapiens_hsa05144 | 1.53412287 |
29 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.53394259 |
30 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 1.53076671 |
31 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.51687209 |
32 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.40335898 |
33 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.40260927 |
34 | Circadian rhythm_Homo sapiens_hsa04710 | 1.39440231 |
35 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.38739559 |
36 | Salmonella infection_Homo sapiens_hsa05132 | 1.38129528 |
37 | Influenza A_Homo sapiens_hsa05164 | 1.37336952 |
38 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.37210049 |
39 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.32676147 |
40 | Tuberculosis_Homo sapiens_hsa05152 | 1.32271996 |
41 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.31789215 |
42 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.31155164 |
43 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.30758910 |
44 | Hepatitis B_Homo sapiens_hsa05161 | 1.27621681 |
45 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.26775301 |
46 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.25647293 |
47 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.22985318 |
48 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.22128015 |
49 | Pertussis_Homo sapiens_hsa05133 | 1.18008593 |
50 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.15935049 |
51 | Amoebiasis_Homo sapiens_hsa05146 | 1.15920095 |
52 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.14553974 |
53 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.13276778 |
54 | Apoptosis_Homo sapiens_hsa04210 | 1.10537672 |
55 | Hepatitis C_Homo sapiens_hsa05160 | 1.09042111 |
56 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.08641403 |
57 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.07455965 |
58 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.06361803 |
59 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.04946973 |
60 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.03657632 |
61 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.03210176 |
62 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.02629250 |
63 | Adherens junction_Homo sapiens_hsa04520 | 1.02614989 |
64 | Glioma_Homo sapiens_hsa05214 | 1.00846137 |
65 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.00270572 |
66 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.00265026 |
67 | ABC transporters_Homo sapiens_hsa02010 | 0.99557119 |
68 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.96635348 |
69 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.94864370 |
70 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.93751392 |
71 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.93102941 |
72 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.92666174 |
73 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.92064088 |
74 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.90881874 |
75 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.90625110 |
76 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.90110822 |
77 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.89929442 |
78 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.88818691 |
79 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.88534275 |
80 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.88225180 |
81 | Galactose metabolism_Homo sapiens_hsa00052 | 0.83550601 |
82 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.83448628 |
83 | Measles_Homo sapiens_hsa05162 | 0.83019637 |
84 | Prostate cancer_Homo sapiens_hsa05215 | 0.83018800 |
85 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.81916015 |
86 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.81606569 |
87 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.81389197 |
88 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.80478350 |
89 | Mismatch repair_Homo sapiens_hsa03430 | 0.79915151 |
90 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.79178950 |
91 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.78986513 |
92 | Lysosome_Homo sapiens_hsa04142 | 0.77070082 |
93 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.76072075 |
94 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.73962124 |
95 | Thyroid cancer_Homo sapiens_hsa05216 | 0.73829000 |
96 | Shigellosis_Homo sapiens_hsa05131 | 0.73807344 |
97 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.73182433 |
98 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.73111365 |
99 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.73022105 |
100 | Bile secretion_Homo sapiens_hsa04976 | 0.71975690 |
101 | Endocytosis_Homo sapiens_hsa04144 | 0.71763336 |
102 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.71718564 |
103 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.71582582 |
104 | Focal adhesion_Homo sapiens_hsa04510 | 0.71552210 |
105 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.70197754 |
106 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.70185842 |
107 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.70130742 |
108 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.69113101 |
109 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.69103199 |
110 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.68667588 |
111 | Prion diseases_Homo sapiens_hsa05020 | 0.67950487 |
112 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.67874745 |
113 | HTLV-I infection_Homo sapiens_hsa05166 | 0.66357039 |
114 | Histidine metabolism_Homo sapiens_hsa00340 | 0.66224588 |
115 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.65835246 |
116 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.65511126 |
117 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.65354368 |
118 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.62750924 |
119 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.62527904 |
120 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.62516365 |
121 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.60393967 |
122 | Legionellosis_Homo sapiens_hsa05134 | 0.59889977 |
123 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.59735791 |
124 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.58666687 |
125 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.57737129 |
126 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.57609856 |
127 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.56097845 |
128 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.55826122 |
129 | Long-term potentiation_Homo sapiens_hsa04720 | 0.54295952 |
130 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.53500981 |
131 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.53489731 |
132 | Peroxisome_Homo sapiens_hsa04146 | 0.52605832 |
133 | Insulin resistance_Homo sapiens_hsa04931 | 0.52295304 |
134 | Platelet activation_Homo sapiens_hsa04611 | 0.51599332 |
135 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.51082578 |
136 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.50896117 |
137 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.50855587 |
138 | Phagosome_Homo sapiens_hsa04145 | 0.49923582 |
139 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.48093076 |
140 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.47694003 |
141 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.45600363 |
142 | Viral myocarditis_Homo sapiens_hsa05416 | 0.44667177 |
143 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.43238478 |
144 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.41989050 |
145 | Endometrial cancer_Homo sapiens_hsa05213 | 0.41434957 |
146 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.40733586 |
147 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.39480151 |
148 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.38804180 |
149 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.38636959 |
150 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.38280684 |
151 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.38121822 |
152 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.37916847 |
153 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.36204351 |
154 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.35983006 |
155 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.34612327 |
156 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.34426132 |
157 | Gap junction_Homo sapiens_hsa04540 | 0.33666442 |
158 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.32937890 |
159 | Colorectal cancer_Homo sapiens_hsa05210 | 0.32256841 |
160 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.32022474 |
161 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.31333855 |
162 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.29712344 |